TerminatedPhase 2NCT05168475

Biologics in Refractory Vasculitis: A Trial of Biologic Therapy for Refractory Primary Non-ANCA Associated Vasculitis

Studying Giant cell arteritis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Cambridge University Hospitals NHS Foundation Trust
Principal Investigator
David Jayne
Cambridge University Hospitals NHS Foundation Trust/University of Cambridge
Intervention
Rituximab(biological)
Enrollment
22 enrolled
Eligibility
5 years · All sexes
Timeline
20212023

Study locations (5)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05168475 on ClinicalTrials.gov

Other trials for Giant cell arteritis

Additional recruiting or active studies for the same condition.

See all trials for Giant cell arteritis

← Back to all trials